Abstract
The objective: of this work is to determine the effectiveness of hepatoprotection of heparisin in patients with unstable angina in combination with non-alcoholic fatty liver disease.Material and methods. 42 patients with unstable angina were examined, including 24 patients with unstable angina in combination with non-alcoholic fatty liver disease, 18 patients with unstable angina, and 20 control subjects. Patients with combined pathology received a hepatoprotection. Patients were evaluated for lipid spectrum and functional status of the liver.Results. When evaluating the blood lipid spectrum in patients with unstable angina revealed dyslipidemia. After treatment in both groups, there was an improvement in lipogram. In patients with unstable angina with concomitant NAFLD, some increase in the level of transaminases and a decrease in their level after treatment was noted.Conclusion. The use of heparisin in patients with unstable angina in combination with NAFLD had a positive effect on the functional state of the liver and contributed to the reduction of transaminases after treatment. There was no significant effect of heparisin on blood lipid spectrum enhancement.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
